Novo Nordisk - ADR Shares Climb 6.2% Past Previous 52-Week High - Market Mover
The shares rose 6.2% higher than its previous 52-week high of $109.02, with trading volume higher than its 30 day average
Feb 01, 2024 by Kwhen Finance Editors
Novo Nordisk - ADR (NVO) shares closed 6.2% higher than its previous 52 week high, giving the company a market cap of $374B. The stock is currently up 5.4% year-to-date, up 59.9% over the past 12 months, and up 412.9% over the past five years. This week, the Dow Jones Industrial Average rose 0.9%, and the S&P 500 rose 1.6%.
Trading Activity
- Trading volume this week was 172.1% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.5.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Novo Nordisk - ADR | 0.9 | 5.4 | 59.9 | 4.6 | 76.1 |
| Dow Jones Industrial Average | 1.0 | 1.8 | 15.9 | -0.5 | 24.2 |
| S&P 500 Index | 1.3 | 3.4 | 23.8 | -1.4 | 30.2 |
| Technology Industry | -3.4 | -15.6 | -70.8 | -70.2 | 12.1 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by 286.6%
- The company's stock price performance over the past 12 months beats the peer average by 847.5%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Novo Nordisk - ADR | NVO | 0 | 5.4 | 59.9 | 4.6 | 76.1 |
| Peer Avg | N/A | 32.8 | 1.4 | 6.3 | -13.8 | 23.7 |
| Lilly(Eli) & Co | LLY | 122.7 | 10.6 | 90.4 | -0.4 | 110.0 |
| Pfizer Inc. | PFE | 14.8 | -3.1 | -34.0 | -36.1 | 6.4 |
| Sanofi - ADR | SNY | 14.2 | 1.1 | 3.7 | ||
| Bristol-Myers Squibb Co. | BMY | 12.2 | -1.7 | -28.5 | -32.6 | 2.3 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: